Literature DB >> 7977827

Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation.

J P Kinsella1, D D Ivy, S H Abman.   

Abstract

To determine maturation-related changes in nitric oxide (NO) activity in the developing pulmonary circulation, we studied the hemodynamic effects of endogenous NO inhibition under basal conditions in the premature ovine fetus and the response to birth-related stimuli and exogenous NO in 30 fetal sheep at three different gestational ages. At 0.95 term, pulmonary vasodilation during inhaled NO (20 parts per million) was equivalent to the dilator response to 100% O2, but at 0.86 term vasodilation during inhaled NO was greater than the dilator response to 100% O2 (P < 0.05). At 0.78 term, left pulmonary arterial flow (QLPA) did not increase with exposure to either NO or 100% O2. Intrapulmonary infusion of nitro-L-arginine (L-NA) increased basal pulmonary vascular resistance 38% in the premature fetus at 0.78 term. L-NA treatment decreased the ventilation-induced rise in QLPA by 60% compared with controls (P < 0.05). Inhaled NO but not 100% O2 increased QLPA after L-NA treatment to levels achieved with ventilation alone in the controls. We conclude that in the premature pulmonary circulation (0.78 term) 1) basal pulmonary vascular resistance is modulated by endogenous NO, 2) pulmonary vasodilation at birth is partly mediated by endogenous NO activity, and 3) inhaled NO causes potent vasodilation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977827     DOI: 10.1152/ajpheart.1994.267.5.H1955

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Nitric oxide synthase immunoreactivity in human bladder carcinoma.

Authors:  M Shochina; Y Fellig; M Sughayer; G Pizov; K Vitner; D Podeh; A Hochberg; I Ariel
Journal:  Mol Pathol       Date:  2001-08

2.  Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.

Authors:  Marc Chester; Gregory Seedorf; Pierre Tourneux; Jason Gien; Nancy Tseng; Theresa Grover; Jason Wright; Johannes-Peter Stasch; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

3.  Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced surfactant deficiency and meconium instillation.

Authors:  M F Krause; H G Lienhart; J Haberstroh; T Hoehn; J Schulte-Mönting; J U Leititis
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

Review 4.  The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.

Authors:  S Lakshminrusimha; O D Saugstad
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

5.  Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.

Authors:  Marc Chester; Pierre Tourneux; Greg Seedorf; Theresa R Grover; Jason Gien; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

Review 6.  Hemoglobin oxygen saturation targets in the neonatal intensive care unit: Is there a light at the end of the tunnel? 1.

Authors:  Payam Vali; Mark Underwood; Satyan Lakshminrusimha
Journal:  Can J Physiol Pharmacol       Date:  2018-10-26       Impact factor: 2.273

Review 7.  Pulmonary Hypertension: The Hidden Danger for Newborns.

Authors:  Steven H Abman
Journal:  Neonatology       Date:  2021-05-05       Impact factor: 4.035

Review 8.  Modulation of pulmonary vasomotor tone in the fetus and neonate.

Authors:  N S Ghanayem; J B Gordon
Journal:  Respir Res       Date:  2001-03-08

Review 9.  The Fetus Can Teach Us: Oxygen and the Pulmonary Vasculature.

Authors:  Payam Vali; Satyan Lakshminrusimha
Journal:  Children (Basel)       Date:  2017-08-03

Review 10.  Oxygen therapy in preterm infants with pulmonary hypertension.

Authors:  Praveen Chandrasekharan; Satyan Lakshminrusimha
Journal:  Semin Fetal Neonatal Med       Date:  2019-12-03       Impact factor: 3.726

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.